85 related articles for article (PubMed ID: 10629645)
21. Apoptosis and Fas-ligand expression correlate to the histopathological grade of gastric smooth muscle tumors.
Liu Y; Chen C; Chen C; Hsieh H; Chang C; Shyu J; Yen C; Harn H
J Surg Res; 2001 Feb; 95(2):92-8. PubMed ID: 11162031
[TBL] [Abstract][Full Text] [Related]
22. Interleukin (IL)-12 and IL-12 gene transfer up-regulate Fas expression in human osteosarcoma and breast cancer cells.
Lafleur EA; Jia SF; Worth LL; Zhou Z; Owen-Schaub LB; Kleinerman ES
Cancer Res; 2001 May; 61(10):4066-71. PubMed ID: 11358827
[TBL] [Abstract][Full Text] [Related]
23. The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer.
Sjöström J; Blomqvist C; von Boguslawski K; Bengtsson NO; Mjaaland I; Malmström P; Ostenstadt B; Wist E; Valvere V; Takayama S; Reed JC; Saksela E
Clin Cancer Res; 2002 Mar; 8(3):811-6. PubMed ID: 11895913
[TBL] [Abstract][Full Text] [Related]
24. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
[TBL] [Abstract][Full Text] [Related]
25. Expression of Fas and Fas-related molecules in human hepatocellular carcinoma.
Lee SH; Shin MS; Lee HS; Bae JH; Lee HK; Kim HS; Kim SY; Jang JJ; Joo M; Kang YK; Park WS; Park JY; Oh RR; Han SY; Lee JH; Kim SH; Lee JY; Yoo NJ
Hum Pathol; 2001 Mar; 32(3):250-6. PubMed ID: 11274632
[TBL] [Abstract][Full Text] [Related]
26. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M
J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692
[TBL] [Abstract][Full Text] [Related]
27. In vivo activation of invariant V alpha 14 natural killer T cells by alpha-galactosylceramide sequentially induces Fas-dependent and -independent cytotoxicity.
Lisbonne M; Hachem P; Tonanny MB; Fourneau JM; Sidobre S; Kronenberg M; Van Endert P; Dy M; Schneider E; Leite-de-Moraes MC
Eur J Immunol; 2004 May; 34(5):1381-8. PubMed ID: 15114671
[TBL] [Abstract][Full Text] [Related]
28. Balanced regulation of mRNA production for Fas and Fas ligand in lymphocytes from centenarians: how the immune system starts its second century.
Pinti M; Troiano L; Nasi M; Bellodi C; Ferraresi R; Mussi C; Salvioli G; Cossarizza A
Circulation; 2004 Nov; 110(19):3108-14. PubMed ID: 15505087
[TBL] [Abstract][Full Text] [Related]
29. Stromal derived factor-1 alpha (SDF-1 alpha) induces CD4+ T cell apoptosis via the functional up-regulation of the Fas (CD95)/Fas ligand (CD95L) pathway.
Colamussi ML; Secchiero P; Gonelli A; Marchisio M; Zauli G; Capitani S
J Leukoc Biol; 2001 Feb; 69(2):263-70. PubMed ID: 11272277
[TBL] [Abstract][Full Text] [Related]
30. [Expression and significance of Fas/APO-1 and bcl-2 protein in renal cell carcinoma].
Li H; Yu L; Yang B; Kong X; Mi P; Guo Y
Zhonghua Wai Ke Za Zhi; 1998 Jul; 36(7):409-11. PubMed ID: 11825426
[TBL] [Abstract][Full Text] [Related]
31. Clinical and biological effects of gamma interferon and the combination of gamma interferon and interleukin-2 after autologous bone marrow transplantation.
Vey N; Viens P; Fossat C; Olive D; Sainty D; Baume D; Stoppa AM; Bouabdallah R; Brandely M; Gastaut JA; Maraninchi D; Blaise D
Eur Cytokine Netw; 1997 Dec; 8(4):389-94. PubMed ID: 9459619
[TBL] [Abstract][Full Text] [Related]
32. Cell activation and death (apoptosis) induced by IL-2: ultrastructural evidence.
Capelli E; Barni S; Vaccarone R; Fortis C; Nano R
Anticancer Res; 1996; 16(4A):1775-80. PubMed ID: 8712700
[TBL] [Abstract][Full Text] [Related]
33. Immunomodulation during prolonged treatment with combined interleukin-2 and interferon-alpha in patients with advanced malignancy.
von Rohr A; Ghosh AK; Thatcher N; Stern PL
Br J Cancer; 1993 Jan; 67(1):163-71. PubMed ID: 7678979
[TBL] [Abstract][Full Text] [Related]
34. In vitro folate deficiency induces apoptosis by a p53, Fas (Apo-1, CD95) independent, bcl-2 related mechanism in phytohaemagglutinin-stimulated human peripheral blood lymphocytes.
Lin HL; Chen CJ; Tsai WC; Yen JH; Liu HW
Br J Nutr; 2006 May; 95(5):870-8. PubMed ID: 16611376
[TBL] [Abstract][Full Text] [Related]
35. Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1/Fas)-CD95 ligand-induced suicide.
Buechner SA; Wernli M; Harr T; Hahn S; Itin P; Erb P
J Clin Invest; 1997 Dec; 100(11):2691-6. PubMed ID: 9389732
[TBL] [Abstract][Full Text] [Related]
36. Low-dose recombinant interleukin-2 therapy: rationale and potential clinical applications.
Caligiuri MA
Semin Oncol; 1993 Dec; 20(6 Suppl 9):3-10. PubMed ID: 8284689
[TBL] [Abstract][Full Text] [Related]
37. Interferon alpha prevents spontaneous apoptosis of clonal Th2 cells associated with chronic hypereosinophilia.
Schandené L; Roufosse F; de Lavareille A; Stordeur P; Efira A; Kennès B; Cogan E; Goldman M
Blood; 2000 Dec; 96(13):4285-92. PubMed ID: 11110703
[TBL] [Abstract][Full Text] [Related]
38. Dysregulated Fas and Bcl-2 expression leading to enhanced apoptosis in T cells of multiple myeloma patients.
Massaia M; Borrione P; Attisano C; Barral P; Beggiato E; Montacchini L; Bianchi A; Boccadoro M; Pileri A
Blood; 1995 Jun; 85(12):3679-87. PubMed ID: 7540069
[TBL] [Abstract][Full Text] [Related]
39. Derangement of apoptosis-related lymphocyte homeostasis in systemic sclerosis.
Stummvoll GH; Aringer M; Smolen JS; Köller M; Kiener HP; Steiner CW; Bohle B; Knobler R; Graninger WB
Rheumatology (Oxford); 2000 Dec; 39(12):1341-50. PubMed ID: 11136877
[TBL] [Abstract][Full Text] [Related]
40. Association of the blood serum cytokines' rate and lymphocytes' apoptosis with polymorphic variants of the BCL-2 (rs17759659), CTLA-4 (rs231775) and APO-1÷FAS (rs2234767) genes in patients with nodular goiters in autoimmune thyroiditis and thyroid adenoma.
Sheremet MI; Sydorchuk LP; Shidlovskyi VO; Sydorchuk RI; Shidlovskyi OV; Maksymyuk VV; Bezruk VV; Tkachuk NP; Batig VM; Mytchenok OV; Bezruk TO; Chympoi KA
Rom J Morphol Embryol; 2017; 58(3):931-939. PubMed ID: 29250672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
